BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 25248369)

  • 1. Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.
    Chang YC; Wang JH; Chen YS; Lin JS; Cheng CF; Chu CH
    BMC Public Health; 2014 Sep; 14():991. PubMed ID: 25248369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Booster Response to Hepatitis B Vaccine at 15 years of age: A Cross-Sectional School-Based Study.
    Chen YS; Chu CH; Wang JH; Lin JS; Chang YC
    Pediatr Neonatol; 2016 Aug; 57(4):302-9. PubMed ID: 26750404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of compulsory and booster doses of hepatitis B vaccine among children in Cairo, Egypt.
    Salama I; Sami S; Saleh R; Mohsen A; Elserougy S; Emam H; Said Z
    J Egypt Public Health Assoc; 2017 Jun; 92(2):77-85. PubMed ID: 30184404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of vaccinating infants with a 5 µg recombinant yeast-derived hepatitis B vaccine and the need for a booster dose in China.
    Miao N; Zheng H; Sun X; Zhang G; Wang F
    Sci Rep; 2020 Oct; 10(1):18155. PubMed ID: 33097788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
    Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
    Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early and long term anamnestic response to HBV booster dose among fully vaccinated Egyptian children during infancy.
    Salama II; Sami SM; Said ZN; Salama SI; Rabah TM; Abdel-Latif GA; Elmosalami DM; Saleh RM; Abdel Mohsin AM; Metwally AM; Hassanin AI; Emam HM; Hemida SA; Elserougy SM; Shaaban FA; Fouad WA; Mohsen A; El-Sayed MH
    Vaccine; 2018 Apr; 36(15):2005-2011. PubMed ID: 29530634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
    He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
    Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of protective anti-HBs antibody levels and anamnestic response to HBV booster vaccination: A cross-sectional study among healthcare students 20 years following the universal immunization campaign in Italy.
    Dini G; Toletone A; Barberis I; Debarbieri N; Massa E; Paganino C; Bersi F; Montecucco A; Alicino C; Durando P
    Hum Vaccin Immunother; 2017 Feb; 13(2):440-444. PubMed ID: 27925503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further observations on the immune response to recombinant hepatitis B vaccine after administration to aboriginal and Torres Strait Island children.
    Hanna JN; Faoagali JL; Buda PJ; Sheridan JW
    J Paediatr Child Health; 1997 Feb; 33(1):67-70. PubMed ID: 9069048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance and anamnestic response in isolated hepatitis B core antibody-positive individuals 18 years after neonatal hepatitis B virus vaccination in Taiwan.
    Su FH; Bai CH; Chu FY; Lin YS; Su CT; Yeh CC
    Vaccine; 2012 Jun; 30(27):4034-9. PubMed ID: 22531558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of hepatitis B vaccine boosters among neonatally vaccinated university freshmen in Taiwan.
    Su FH; Chu FY; Bai CH; Lin YS; Hsueh YM; Sung FC; Yeh CC
    J Hepatol; 2013 Apr; 58(4):684-9. PubMed ID: 23207141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Single Center Analysis of the Positivity of Hepatitis B Antibody after Neonatal Vaccination Program in Korea.
    Kim YJ; Li P; Hong JM; Ryu KH; Nam E; Chang MS
    J Korean Med Sci; 2017 May; 32(5):810-816. PubMed ID: 28378555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The positive rates of hepatitis B surface antibody in youth after booster vaccination: a 4-year follow-up study with large sample.
    Zhu X; Wang J; Wang M; Du LY; Ji YL; Zhang X; Tang H
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34151935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Waning immunity and booster responses in nursing and medical technology students who had received plasma-derived or recombinant hepatitis B vaccine during infancy.
    Lin CC; Yang CY; Shih CT; Chen BH; Huang YL
    Am J Infect Control; 2011 Jun; 39(5):408-414. PubMed ID: 21255876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
    Wang Y; Chen T; Lu LL; Wang M; Wang D; Yao H; Fan C; Qi J; Zhang Y; Qu C
    Vaccine; 2017 Feb; 35(7):1064-1070. PubMed ID: 28069363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of three booster doses hepatitis B vaccine on the persistence of immune-protection among infants with normal and high antibody response to primary vaccination: a matched case-control study].
    Feng Y; Lyu J; Liu J; Yan B; Song L; Liang X; Li L; Zhang G; Wang F; Zhang L; Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Apr; 37(4):460-3. PubMed ID: 27087206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse immune responses to HBV surface epitope variants after vaccine booster in adolescents immunized in infancy.
    Lai MW; Liang KH; Yeh CT
    Clin Microbiol Infect; 2019 Sep; 25(9):1140-1146. PubMed ID: 30771531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.